Burney CO Amgen Inc Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Amgen Inc stock. As of the latest transaction made, Burney CO holds 19,916 shares of AMGN stock, worth $5.25 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

19,916

Previous 20,126 1.04%

Holding current value

$5.25 Million

Previous $6.29 Million 2.05%

% of portfolio

0.25%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $64,969 - $70,849	-210 Reduced 1.04%	19,916 $6.42 Million
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $93,276 - $113,355	-355 Reduced 1.73%	20,126 $6.29 Million
Q1 2024 May 22, 2024	SELL	$268.87 - $324.56 $261,879 - $316,121	-974 Reduced 4.54%	20,481 $5.82 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $64,436 - $72,691	-252 Reduced 1.16%	21,455 $6.18 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $390,727 - $485,099	-1,787 Reduced 7.61%	21,707 $5.83 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $1.17 Million - $1.39 Million	-5,475 Reduced 18.9%	23,494 $5.22 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $1.14 Million - $1.39 Million	-5,069 Reduced 14.89%	28,969 $7 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $750,760 - $953,930	-3,278 Reduced 8.78%	34,038 $8.94 Million
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $2.55 Million - $2.88 Million	-11,363 Reduced 23.34%	37,316 $8.41 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $297,846 - $331,451	1,291 Added 2.72%	48,679 $11.8 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $95,163 - $105,275	-434 Reduced 0.91%	47,388 $11.5 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $301,104 - $344,586	-1,514 Reduced 3.07%	47,822 $10.8 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $198,896 - $233,031	-937 Reduced 1.86%	49,336 $10.5 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $210,455 - $233,485	-901 Reduced 1.76%	50,273 $12.3 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $174,865 - $203,776	788 Added 1.56%	51,174 $12.7 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $254,030 - $302,504	-1,174 Reduced 2.28%	50,386 $11.6 Million
Q3 2020 Dec 14, 2020	SELL	$234.65 - $260.95 $267,501 - $297,483	-1,140 Reduced 2.16%	51,560 $13.1 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $141,038 - $173,073	-713 Reduced 1.33%	52,700 $12.4 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $512,458 - $679,660	-2,812 Reduced 5.0%	53,413 $10.8 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.03 Million - $1.33 Million	5,455 Added 10.74%	56,225 $13.6 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $3.43 Million - $4.11 Million	19,697 Added 63.39%	50,770 $9.82 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $591,618 - $693,510	3,549 Added 12.89%	31,073 $5.73 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $563,229 - $634,882	3,114 Added 12.76%	27,524 $5.23 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $337,889 - $394,425	1,894 Added 8.41%	24,410 $4.75 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $894,024 - $1.01 Million	-4,825 Reduced 17.65%	22,516 $4.67 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $2.01 Million - $2.26 Million	12,122 Added 79.65%	27,341 $5.05 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $221,953 - $259,380	-1,310 Reduced 7.93%	15,219 $2.6 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.09 Million - $1.22 Million	6,471 Added 64.34%	16,529 $2.87 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $104,556 - $119,375	625 Added 6.63%	10,058 $1.87 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $1.58 Million - $1.8 Million	9,433	9,433 $1.63 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account